A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule

Author： Fyfe D.   Price C.   Langley R.E.   Pagonis C.   Houghton J.   Osborne L.   Woll P.J.   Gardner C.   Baguley B.C.   Carmichael J.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.47, Iss.4, 2001-04, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase I Trial of Gemcitabine Administered as a 96-h Continuous Intravenous Infusion in Patients with Advanced Carcinoma and Lymphoma

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 369-376

Humana Press, Inc

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of 5-day Chronomodulated Infusion of 5-Fluorouracil and 1-Folinic Acid in Patients with Metastatic Colorectal Cancer

By Garufi C.   Levi F.   Aschelter A.M.   Pace R.   Giunta S.   Nistico C.   Galla D.A.P.   Silecchia G.F.   Franchi F.   Narduzzi C.   Terzoli E.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1566-1571

Elsevier

Access to resources Recommend Favorite

Phase I trial of systemic intravenous infusion of interleukin‐13‐Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma

By  

Cancer Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1060-1068

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer

By Kambe Mariko   Kikuchi Hiroaki   Gamo Makio   Yoshioka Takashi   Ohashi Yasuo   Kanamaru Ryunosuke  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 150-154

Springer Publishing Company

Access to resources Recommend Favorite